Transthyretin (TTR) cardiac amyloidosis (CA) is an increasingly recognized cause of heart failure. Diagnosis of TTR-CA relies on visual and semi-quantitative interpretation of planar 99mTc-PYP imaging. However, new methods that… Click to show full abstract
Transthyretin (TTR) cardiac amyloidosis (CA) is an increasingly recognized cause of heart failure. Diagnosis of TTR-CA relies on visual and semi-quantitative interpretation of planar 99mTc-PYP imaging. However, new methods that directly quantify PYP uptake may improve risk stratification and/or
               
Click one of the above tabs to view related content.